학술논문
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer
Document Type
Article
Author
Tsimberidou, A.M.; Norris, B.; Ort, R.; Beck, J.; Vo, H.H.; Guenther, K.; Mendrzyk, R.; Wagner, C.; Nowak, A.; Aslan, K.; Richter, F.; Kuttruff-Coqui, S.; Schoor, O.; Fritsche, J.; Hoffgaard, F.; Ruh, M.; Backert, L.; Fuhrmann, D.; Hilf, N.; Maurer, D.; Andersson, B.S.; Kebriaei, P.; Shpall, E.J.; Alpert, A.; Satelli, A.; Coughlin, Z.; Mohamed, A.S.; Sieger, K.; Walter, S.; Wistuba, I.I.; Ibrahim, N.K.; Morris, V.K.; Kee, B.K.; Halperin, D.M.; Nogueras-Gonzalez, G.M.; Vining, D.; Hwu, P.; Singh, H.; Reinhardt, C.; Britten, C.M.; Weinschenk, T.
Source
In: Cancer Immunology Research . (Cancer Immunology Research, 1 July 2023, 11(7):925-945)
Subject
Language
English
ISSN
23266074
23266066
23266066